Skip to main content
Midas Edge

WISA TECHNOLOGIES INC

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

DVLT$0.06+3.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity

CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands, except share data)

​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Total
​ · ​ · Convertible Preferred Stock · ​ · ​ · Common Shares · ​ · Additional · ​ · Accumulated · ​ · Stockholders'
​ · ​ · Shares · ​ · Amount · ​ · Shares · ​ · Amount · ​ · Paid-in Capital · ​ · Deficit · ​ · Equity (Deficit)
Balance as of December 31, 2021—​—​158,310​2​​228,578​(212,203)​16,377
ASC 842 adoption adjustment​—​​—​​—​​—​​—​​33​​33
Stock-based compensation​—​​—​​12,749​​—​​2,027​​—​​2,027
Release of vested restricted common stock​—​​—​​2,108​​—​​—​​—​​—
Restricted stock awards cancelled​—​​—​​(603)​​—​​—​​—​​—
Issuance of warrants in connection with convertible promissory note​—​​—​​—​​—​​91​​—​​91
Issuance of common stock and warrants, net of offering costs​—​​—​​540,000​​5​​6,426​​—​​6,431
Issuance of warrants in connection with December 2022 offering​—​​—​​—​​—​​(10,804)​​—​​(10,804)
Net loss​—​​—​​—​​—​​—​​(16,151)​​(16,151)
Balance as of December 31, 2022—​​—​712,564​$7​$226,318​$(228,321)​$(1,996)
Stock-based compensation​—​​—​​964,041​​—​​2,058​​—​​2,058
Restricted stock awards cancelled​—​​—​​(13,288)​​—​​—​​—​​—
Release of vested restricted common stock​—​​—​​2,919​​—​​—​​—​​—
Issuance of common stock in connection with convertible promissory note​—​​—​​67,500​​—​​708​​—​​708
Issuance of common stock in connection with warrant exercise​—​​—​​2,854,485​​—​​10,713​​—​​10,713
Issuance of common stock and warrants, net of offering costs​—​​—​​2,176,435​​—​​2,319​​—​​2,319
Issuance of Series B preferred stock, net of discounts​87,000​​—​​—​​—​​1,909​​—​​1,909
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts​61,613​​3,550​​—​​—​​195​​—​​195
Issuance of common stock in connection with conversion of Series B preferred stock​(110,278)​​(6,341)​​26,592,199​​—​​6,341​​—​​6,341
Deemed dividend on conversion of convertible preferred for common stock​—​​6,063​​—​​—​​(6,063)​​—​​(6,063)
Repurchase of common stock warrants​—​​—​​—​​—​​(2,323)​​—​​(2,323)
Amortization and accretion of discounts relating to Series B preferred stock​—​​297​​—​​—​​(297)​​—​​(297)
Discount from issuance of common stock warrants in connection with Series B preferred stock inducement​—​​(3,322)​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​—​​(18,721)​​(18,721)
Balance as of December 31, 2023​38,335​$247​​33,356,855​$7​$241,878​$(247,042)​$(5,157)

Note: Share amounts have been retroactively adjusted to reflect the impact of a 1-for-100 reverse stock split effected in January 2023, as discussed in Note 1.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.